VP, Technology & Innovation, PerkinElmer
Karen is Vice President of Technology and Innovation and is responsible for helping drive innovation across all of PerkinElmer businesses and end markets, including diagnostics, life science, analytical and food. This includes driving collaboration internally and externally – including chairing PerkinElmer’s Technology & Innovation Council, establishing strategic partnerships, and using creative funding mechanisms. Karen is also responsible for identifying new markets, technologies, and innovative, customer driven product offerings – including promoting internal idea generation, championing ideas that cross business, and infusing customer voice into PerkinElmer’s innovation efforts. She is also part of PerkinElmer’s Senior Leadership Team reporting to the CEO.
Dr. Madden was formerly President of PerkinElmer’s Informatics business, a leading specialized software provider to the scientific research and development market. PerkinElmer Informatics is a leader in electronic laboratory notebooks (ELN) and scientific desktop (ChemDraw) software, as well as analytics and visualization (Spotfire) in scientific research, development and manufacturing markets. Prior to serving as President of the Informatics business, Dr. Madden held various leadership and business development positions within PerkinElmer in the Diagnostic and Emerging Technologies businesses. Dr. Madden joined PerkinElmer in 2010 through an acquisition of VisEn, a molecular imaging company, where she served as Vice President of Business Development and Corporate Development.
Prior to joining VisEn, she was a Director at Feinstein Kean Healthcare and Kendall Strategies, leading business strategy and working with a range of clients from small start-ups to multi-national biopharmaceutical companies conducting business strategy, due diligence, valuation analyses, and qualitative and quantitative market research. Dr. Madden holds a B.A. in Chemistry from Boston University and a M.S. from the University of Pennsylvania. She did her doctoral work in Chemistry at Rutgers University, where she determined the three-dimensional X-ray crystallographic structures of human viruses and viral proteins.
Karen has also held several other leadership positions within PerkinElmer, including serving as President of Informatics and as a Sr. Director in the Emerging Technologies group as business development and technology evaluation. Prior to PerkinElmer, Karen was part of the leadership team at VisEn, a molecular in vivo imaging company that was acquired by PerkinElmer in 2010. She also worked in a strategic management consulting role for several years with a leading full service communications and business consulting firm specializing in the healthcare industry. Karen was originally trained as a scientist and has a Ph.D. in Chemistry.
Karen is married and her husband Stephen is Vice President of Translational Science and Genomics at Sanofi Genzyme. They reside together in Sudbury, MA with their two children ages 16 and 19.